Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Filtry

163 581 (0,19s)

Výsledek výzkumu

European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Summary of the document prepared by the Czech Society

Practical start-up and follow-up scheme for patients on new oral anticoagulants. How to measure the anticoagulant effect of new oral anticoagulants? Drug-drug interactions and pharmacokin...

FA - Kardiovaskulární nemoci včetně kardiochirurgie

  • 2014
  • Jx
  • Odkaz
Výsledek výzkumu

New Oral Anticoagulants

The seminar will be oriented to the pharmaceutical care of patients with anticoagulant therapy, focusing on New Oral Anticoagulants (NOAC). Indications of these drugs, their pharmacokinetic parameters in relation t...

Pharmacology and pharmacy

  • 2019
  • O
Výsledek výzkumu

Use of new anticoagulants ? preliminary results of an epidemiological study and possible recommendations.

Until recently, warfarin was the only oral anticoagulant. Because of its numerous side effects, new oral anticoagulants have beendeveloped. Now we have two groups of substances, namely oral direct...

Cardiac and Cardiovascular systems

  • 2018
  • Jost
  • Odkaz
Výsledek výzkumu

New oral anticoagulants-a review

Until recently, warfarin was the only anticoagulant used in medical care. Because of its numerous side effects, in particular different types of bleeding, a few new oral anticoagulants with equal or better safety t...

FN - Epidemiologie, infekční nemoci a klinická imunologie

  • 2016
  • Jx
Výsledek výzkumu

Epidemiological study of new oral anticoagulants

Purpose: New oral anticoagulants are a big step forward in the area of patients using new oral anticoagulants and to optimize the treatment of each patient from a network of cardiac outpatients we...

Cardiac and Cardiovascular systems

  • 2018
  • Jost
  • Odkaz
Výsledek výzkumu

New anticoagulants

Until recently, warfarin was the only peroral anticoagulant. Due to its numerous side effects, especiallyof various types of bleeding, a new oral anticoagulant with the same or better safety was developed. Patients...

Cardiac and Cardiovascular systems

  • 2017
  • Jost
  • Odkaz
Výsledek výzkumu

Blood coagulation disturbancies in geriatrics

The chapter brings a overview of primary and secondary coagulation and fibrinolysis. There is given the overview of indications and contraindications of aggregation and anticoagulation. Attention is paid to new oral ant...

FP - Ostatní lékařské obory

  • 2015
  • C
Výsledek výzkumu

Blood coagulation disturbancies in geriatrics

The chapter brings a overview of primary and secondary coagulation and fibrinolysis. There is given the overview of indications and contraindications of aggregation and anticoagulation. Attention is paid to new oral ant...

FP - Ostatní lékařské obory

  • 2015
  • C
Výsledek výzkumu

Epidemiological study of new oral anticoagulants

Purpose: New oral anticoagulants are a big step forward in the area a network of cardiac outpatients were used in the study of new oral anticoagulants%). The most commoninitial diagnosis for presc...

Cardiac and Cardiovascular systems

  • 2018
  • JSC
  • Odkaz
Výsledek výzkumu

New oral anticoagulants: Which direction goes further development? New oral anticoagulants: Which direction goes further development? New oral anticoagulants: Which direction goes further development

New oral anticoagulants (NOAC) currently have a clearly defined indications priority to the prevention of thromboembolic complications in orthopedic surgery, atrial fibrillation, the treatment of deep vein thrombosis and lo...

FA - Kardiovaskulární nemoci včetně kardiochirurgie

  • 2015
  • C
  • 1 - 10 z 163 581